Biotech Values

[Mufaso]

Lundbeck to Acquire Longboard Pharmaceuticals for $60 (a $2.6B deal) and the stock is up approx 45% pre market. Longboard Pharmaceuticals was a spinout of the former Arena Pharmaceuticals prior to Arena being purchased by PFE (Pfizer acquired Arena Pharmaceuticals for $6.7 billion in March 2022.) Longboard (a San Diego company) has a focus on GPCRs' for Neurological And Rare Diseases.

Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline

https://finance.yahoo.com/news/lundbeck-acquire-longboard-pharmaceuticals-strategic-103000932.html